• Product NameSpiramycin
• Brief DescriptionInhibitors
• Purification90.00%
• Biological ActivityA macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
• Target NameOthers
• CAS No. 8025-81-8
• Calculated MW 843.07
• Formulation C43H74N2O14
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 100 mg/mL (118.61 mM); DMSO: 100 mg/mL (118.61 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Poulsen SM, et al. J Mol Biol, 2000, 304(3), 471-481.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting